Fig. 1 · Structure
Documents & Downloads
EGIS 11150
Adrenergic Reporter Antagonist
EGIS 11150 is an adrenergic reporter antagonist that exhibits high affinity for adrenergic α1, α2c, and 5-HT2A receptors. This compound demonstrates notable antipsychotic properties and procognitive efficacy, making it a valuable tool in the study of neuropsychiatric disorders. Its selective interactions support research in understanding the mechanisms of psychotropic effects and potential therapeutic applications.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 494861-87-9 |
| Applications | Adrenergic Reporter Antagonist |
| Formula | C19H21ClFN5O2 |
| Molecular Weight | 405.85 |
| SMILES | O=C1C(Cl)=C(NCCN2CCC(CC2)C3=NOC4=C3C=CC(F)=C4)C=NN1C |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.